Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double Blind, Randomized, Placebo Controlled,Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis Sub study A